[Determination and modification of ureteral motility with drugs].
D004164:Diphosphonates; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006594:Hexoprenaline / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008879:Midodrine / Q000494:pharmacology / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D011183:Postoperative Complications; D011877:Radionuclide Imaging; D013667:Technetium; D013669:Technetium Tc 99m Medronate; D014513:Ureter / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology*; D002583:Uterine Cervical Neoplasms / Q000601:surgery*
D004164:Diphosphonates; D004983:Ethanolamines; D010627:Phenethylamines; D008879:Midodrine; D013667:Technetium; D006594:Hexoprenaline; D013669:Technetium Tc 99m Medronate
Die Erfassung und medikamentöse Beeinflussung der Ureterenmotilität.